February, 2024
February 2024
Theodore DeWeese: Why we do what we do
Jan 20, 2024, 07:22

Theodore DeWeese: Why we do what we do

shared on LinkedIn:

“As 2024 begins, I’m thinking a great deal about the purpose of Johns Hopkins Medicine and why we do what we do.

Whether we’re providing patient care, making breakthrough discoveries, or training the next generation of physicians and scientists, our goal is to alleviate suffering and make the world a better place.

That’s a pivotal contribution, given the amount of pain in the world today. Violence, incivility and war are on the rise, and times are hard for so many.

What can we do as medical professionals? I believe we can help by approaching each of our missions – to care, to teach, to discover – with greater levels of humanity. This can mean many things:

·      Creating more space to truly listen to patients and know them as individuals.
·      Making top-quality care more convenient and accessible.
·      Pursuing health equity, and inviting more people and more perspectives into the decision-making process.
·      Making our daily work easier so faculty, staff and learners are better able to relax, recharge, and be there for the patients we serve.

At a personal level, it can also mean being kinder and more forgiving. Laughing more. Celebrating and supporting one another as we take on the big challenges ahead.

That’s my intention for 2024. What’s yours? ”

Source: Theodore DeWeese/LinkedIn

Theodore DeWeese is dean of the medical faculty and CEO, Johns Hopkins Medicine. Dr. DeWeese is the Sidney Kimmel Professor of Radiation Oncology and Molecular Radiation Sciences, and is professor of oncology and urology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include prostate cancer, radiation oncology and urological oncology.

Dr. DeWeese earned his M.D. from the University of Colorado Health Sciences Center. He completed his residency at The Johns Hopkins Hospital, serving as chief resident, and performed a laboratory research fellowship at the Johns Hopkins Oncology Center and the James Buchanan Brady Urological Institute.

Dr. DeWeese’s research interests include prostate cancer, DNA damage, and radiation sensitization.

Dr. DeWeese has served on numerous committees and boards including as President and Chair of the Board for the American Society for Radiation Oncology. He also serves on committees for the American Association for Cancer Research and was appointed by the National Academy of Sciences as a scientific counselor for the Radiation Effects Research Foundation in Hiroshima, Japan. He has received numerous awards and honors, including several teaching awards from Johns Hopkins. (from www.hopkinsmedicine.org)